Trueblood Wealth Management’s Marvell Technology MRVL Stock Holding History

Trueblood Wealth Management’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Sell	4,139 -5	-0.1%	-$1K	0.43%	70
2026 Q1	$410K	Sell	4,144 -7	-0.2%	-$588	0.16%	168
2025 Q4	$353K	Sell	4,151 -344	-8%	-$30.1K	0.14%	183
2025 Q3	$378K	Buy	4,495 +2	+0%	+$147	0.15%	180
2025 Q2	$348K	Sell	4,493 -3	-0.1%	-$187	0.15%	185
2025 Q1	$277K	Buy	4,496 +79	+2%	+$7.67K	0.13%	197
2024 Q4	$488K	Sell	4,417 -251	-5%	-$23.3K	0.24%	135
2024 Q3	$337K	Sell	4,668 -276	-6%	-$19.1K	0.17%	163
2024 Q2	$346K	Hold	4,944	–	–	0.2%	145
2024 Q1	$350K	Buy	4,944 +152	+3%	+$10.4K	0.2%	142
2023 Q4	$289K	Buy	+4,792	New	+$259K	0.18%	157

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Trueblood Wealth Management's MRVL Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Marvell Technology (MRVL) stake by 0.12% in Q2 2026, selling an estimated $1K and leaving 4,139 shares worth $1.23M. The position accounts for 0.43% of the portfolio, ranked #70.

Trueblood Wealth Management first reported a position in MRVL in Q4 2023 and has held it in 11 quarters since. 2,207 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Trueblood Wealth Management held 4,139 shares of Marvell Technology worth $1.23M as of Q2 2026.
Trueblood Wealth Management sold 5 Marvell Technology shares in Q2 2026, an estimated $1K.
Marvell Technology made up 0.43% of Trueblood Wealth Management's portfolio in Q2 2026, its #70 holding.
Trueblood Wealth Management first reported a position in Marvell Technology in Q4 2023 and has held it in 11 quarters since.
2,207 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.